Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07770100 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT07770100 · ClinicalTrials.gov record · last posted 2026-08-20

Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)

Name: Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV) — clinical trial record (NCT07770100)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 2

SponsorMark Bernard

Started2026-10-01

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This is a Phase II clinical study for people with stage IV cancer. The study will evaluate the use of stereotactic body radiation therapy (SBRT), a type of focused radiation treatment, together with immunotherapy-based treatment. SRBT will be used to treat multiple areas of cancer that have spread to other parts of the body. The study will evaluate whether this treatment approach can be safely given while patients continue their planned cancer treatment and may help control their cancer.

Trial Details

NCT Number	NCT07770100
Lead Sponsor	Mark Bernard
Conditions	Head and Neck Cancer, Non-Small Cell Lung Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer (GC)
Enrollment	35 participants
Start Date	2026-10-01
Primary Completion	2040-02-28 (estimated)
Study Completion	2040-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-08-20